Jeffrey S. Martini
Chief Scientific Officer · PALVELLA THERAPEUTICS, INC.
Individual
- 2024
- Feb 9, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey S. Martini files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kathleen Goin - $5.09M in PVLA purchases and sales in the last 12 months
- George M. Jenkins - $4.72M in PVLA purchases and sales in the last 12 months
- Elaine J. Heron - $300K in PVLA purchases and sales in the last 12 months
- Christopher P. Kiritsy - $49K in PVLA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey S. Martini?
Jeffrey S. Martini is a corporate insider, tracked as Chief Scientific Officer of PALVELLA THERAPEUTICS, INC. (PVLA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jeffrey S. Martini last file a Form 4?
The most recent primary Form 4 on record is dated 9 February 2026, one of 2 filings going back to 2024.